CELGENE THALIDOMIDE WOULD BE DISTRIBUTED ONLY TO REGISTERED PHARMACIES; REGISTRY WOULD TRACK INDICATION OF EACH Rx; FDA COMMITTEE SUPPORTS LEPROSY USE
Executive Summary
Celgene's proposal for thalidomide distribution would register only a small number of pharmacies that could purchase and dispense the drug. "We do not expect that a high proportion of pharmacies in the U.S. today will be involved," Celgene's Brian Williams told FDA's Dermatologic & Ophthalmic Drugs Advisory Committee meeting Sept. 4.